TAKE Solutions Limited has announced the launch of a dedicated Innovation Fund with an initial corpus of Rs 50 million, aimed at supporting startups operating at the intersection of artificial intelligence, deep technology, and digital health. The initiative reflects the company’s strategic shift toward enabling next-generation, technology-driven business models.
The fund will focus on early- and growth-stage companies that are leveraging data, advanced analytics, and scientific innovation to transform healthcare delivery and improve patient outcomes. By targeting high-potential ventures in emerging sectors, TAKE Solutions aims to build a strong pipeline of scalable and impactful businesses.
India’s health and wellness sector is witnessing rapid expansion, with projections estimating market size to reach $400–500 billion over the next decade. This growth is being driven by increased healthcare awareness, digital adoption, and a growing focus on preventive care. Against this backdrop, the Innovation Fund seeks to address critical gaps in access, affordability, and efficiency through technology-led solutions.
The fund’s investment strategy will span key areas including AI-driven diagnostics, predictive analytics, precision medicine, digital therapeutics, and remote healthcare platforms. It will also support infrastructure technologies that enhance compliance, scalability, and operational efficiency across knowledge-driven industries.
Beyond capital, portfolio companies will benefit from TAKE Solutions’ global ecosystem, including expertise in life sciences, supply chain management, and regulatory frameworks. The company will also provide access to technology infrastructure, institutional partnerships, and established go-to-market channels, helping startups accelerate commercialization and reduce time-to-market.
As part of its broader transformation, TAKE Solutions has also introduced TAKE.Health, an AI-powered digital platform that converts lifestyle and medical data into personalized health insights. The platform is designed to cater to both individual users and enterprise clients, creating scalable and recurring revenue opportunities.
With chronic diseases accounting for a significant share of global health challenges, the convergence of biology and technology is expected to drive the next wave of innovation. TAKE Solutions aims to play a catalytic role in this transformation by backing ventures that combine scientific advancement with scalable business models.
